K-numberK251933
Device nameSnugFit ASA Extension
ApplicantMedacta International S.A.
Product codeMBI
Device classClass II
Decision dateJul 1, 2025
DecisionSubstantially Equivalent
Regulation888.3040
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The SnugFit ASA Extension is a soft tissue fixation device composed entirely of ultra-high molecular weight polyethylene (UHMWPE) and polyester sutures braided to create an anchoring point in bone. It is intended for arthroscopic or open surgical fixation of soft tissue to bone in the hip (acetabular labral repair) and shoulder (glenoid labrum repair, rotator cuff repair, biceps tendon repair). The device consists of a pre-loaded all-suture anchor on a disposable stainless-steel driver with plastic handle.

Technological characteristics

The subject and predicate devices are substantially equivalent in indications for use, sizes, deployment and fixation mechanism, driver design, materials, biocompatibility, device usage, packaging, shelf-life, and sterilization. The only difference is the type and number of preloaded sutures—the subject devices expand the portfolio with new single-loaded, double-loaded, and triple-loaded configurations across Size 1 and Size 2 variants.

Test standards cited

European Pharmacopoeia §2.6.14 (bacterial endotoxin/LAL test, equivalent to USP chapter <85>) and USP chapter <151> (pyrogen test) were used for pyrogenicity determination. Performance testing and biocompatibility assessment were conducted according to written protocols, though specific ISO/IEC/ASTM standards are not cited by name in this summary.

Substantial equivalence argument

Substantial equivalence is supported because the functional mechanism is identical to the predicate devices (K230544, K203485)—the sutures anchor identically in bone and secure soft tissue the same way. The only change is the number and arrangement of preloaded sutures, which expands surgeon choice but introduces no worse-case performance; pull-out force testing confirms equivalence. Since materials, design, sterilization, biocompatibility, and shelf-life are unchanged, and the indications for use remain identical, the device poses no new safety or effectiveness risks compared to already-cleared predicates.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →